Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Dopl develops a software platform that enables specialists to remotely operate medical devices, beginning with telerobotic ultrasound to deliver diagnostic care to underserved communities. The company targets healthcare access disparities through remote robotic and autonomous care delivery.
2 investors
Dreamfold engineers proteins as therapeutic medicines, using generative AI models that reason over protein sequence and structure to enable potent, localized immune modulation with minimal off-target effects.
2 investors
Droplet Biosciences develops cancer diagnostics with a focus on liquid biopsy and precision oncology. The company works in the molecular diagnostics space for cancer detection and personalized medicine.
2 investors
Dxcover develops a multi-omic liquid biopsy platform that combines infrared light spectroscopy and machine learning to detect multiple cancers at an early stage. The platform is aimed at triaging high-risk populations for high-mortality cancers.
2 investors
DYNEX Technologies manufactures fully automated ELISA laboratory systems and diagnostic instruments for clinical and research laboratories. The company provides open-platform automation solutions designed to support multiple assay protocols across diagnostic testing specialties.
2 investors
EarlySight develops cellular-level retinal imaging technology and biomarkers for clinical applications. The company operates in the medtech sector, providing solutions for retinal imaging diagnostics.
2 investors
Ebenbuild develops personalized, predictive digital twins for patients with severe illness, using computational models grounded in physics, physiology, biochemistry, and disease mechanisms. The company applies this digital twin technology to healthcare and life sciences to support more individualized and efficient patient care.
2 investors
EchoPixel is a healthcare technology company developing advanced visualization tools to support patient care in the operating room. Founded in 2012, it works with clinical partners to bring new capabilities to medical procedures.
2 investors
Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology. The company works in the medical device space for cardiovascular care.
2 investors
Eclipse Orthopaedics is developing the Radioscopic Targeting Attachment (RTA), a freehand targeting and drilling device to help surgeons perform distal locking during intramedullary nail fixation of leg and hip fractures with less operative time and reduced radiation exposure. The device is aimed at general surgeons in community hospitals and works with existing nail systems and surgical techniques; it is currently under development and not approved for use in humans.
2 investors
Eco-Inject manufactures sustainable single-use autoinjectors for pharmaceutical applications, using a novel design that reduces component count and carbon emissions while maintaining cost parity with conventional devices. The product addresses pharmaceutical companies' environmental commitments and the growing market for home-based self-injection solutions.
2 investors
Editas Medicine develops gene-editing medicines using CRISPR technology to treat serious genetic diseases. The company discovers, develops, and manufactures genomic medicines for patients worldwide.
2 investors
Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures. Its products serve hospital surgical and cath lab staff, aiming to meet enhanced radiation protection standards.
2 investors
Eirion Thera develops therapeutics focused on aesthetic medicine and medical dermatology. It operates in the biotech and pharmaceutical sector targeting dermatological and aesthetic conditions.
2 investors
electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions. The company operates in the bioelectronic medicine field and sells its products in markets including the US, UK, EU countries, Canada, Australia, New Zealand, and Saudi Arabia.
2 investors
Elevage Medical Technologies provides capital investment and strategic operational support to growth-stage medtech companies, focusing on FDA-regulated medical devices and diagnostics, lab tools, and healthcare IT and tech-enabled services. It works with companies to advance regulatory approval and commercialization of technologies aimed at improving patient health outcomes.
2 investors
Elevara Medicines is a clinical-stage biotech developing ELV001, a first-in-class once-daily oral CDK4/6 inhibitor that targets fibroblast-like synoviocytes as an add-on therapy for rheumatoid arthritis and other chronic inflammatory diseases. Its drug is designed to combine with existing DMARDs for patients who have an inadequate response to standard treatments like methotrexate and TNF inhibitors.
2 investors
Eliksa develops regenerative medicine therapies for rare diseases, processing acellular biological products in its own cGMP facility. Its lead investigational product, ELK-003, is an ophthalmic eye-drop drug targeting the ocular effects of Epidermolysis Bullosa, an ultra-rare genetic disorder affecting children.
2 investors
Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, including ecopipam, an investigational dopamine D1 receptor antagonist for pediatric Tourette syndrome. The company, created by Paragon Biosciences, advanced the asset through clinical development and was acquired by Teva Pharmaceutical Industries in 2026.
2 investors
eMedicalSentry provides remote patient monitoring (RPM) and telehealth services that let hospitals and healthcare providers track and communicate with patients remotely to reduce 30-day readmissions and avoid Medicare penalties. Its care coordination platform works with existing and future devices and includes reporting on individual and population-wide outcomes such as HEDIS/Stars and Homecare Compare quality ratings.
2 investors
EMIT Corporation designs, manufactures, and sells FDA-cleared, CE-marked portable IV fluid and blood warming devices (HypothermX HX100/LG) that use a flameless hydrocarbon combustion process to treat and prevent hypothermia without generated power. Its products serve military, medical, and field-care customers, with a focus on high-end military and Special Operations applications.
2 investors
Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.
2 investors
Endogene is a biotech company focused on uterine biology, developing tools to improve the understanding, diagnosis, and treatment of uterine diseases.
2 investors
Abbott's cardiovascular division provides cardiac and vascular medical devices and technologies, including electrophysiology products for treating conditions such as AFib and remote hemodynamic monitoring for heart failure. It serves healthcare professionals with product, reimbursement, and training resources, as well as patients and caregivers.
2 investors